Drawing for PYTHARO

USPTO serial 79231453

PYTHARO

Reviewed by CopyMark Law Group

Reg. 5552810Status 404
Filing date
Status date
Registration date
Sep 4, 2018
Examiner
BENMAMAN, ALICE
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PYTHARO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial [ pharmaceutical ] * pharmaceuticals * [ preparations ] ; antibiotics; antifungal preparations; antivirals; cardiovascular [ pharmaceutical ] * pharmaceuticals * [ preparations ] ; dermatological pharmaceutical preparations; [ pharmaceutical preparations to be inhaled, for the prevention and treatment of respiratory disorders and diseases; ] * inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; * pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of [ gastrointestinal ] * gastro-intestinal * diseases; pharmaceutical preparations for use the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the [ musculoskeletal ] * musculo-skeletal * system and the [ urogenital ] * genitourinary * system; pharmaceutical preparations [ used ] * for use * in hematology and in [ organ and tissue ] * tissue and organ * transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; [ pharmaceutical preparations for the prevention and treatment of cardiac rhythm disturbances; ] * pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; * [ pharmaceutical preparations for the prevention and treatment of diseases and disorders linked to the immune system; ] * pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; * pharmaceutical preparations for the prevention and treatment of [ renal ] * kidney * diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of [ high blood pressure ] * hypertension * ; pharmaceutical preparations for the prevention and treatment of skin [ diseases ] * disorders * ; pharmaceutical preparations [ used ] * for use * in dermatology; pharmaceutical preparations [ used ] * for use * in urology; [ pharmaceutical preparations used in ophthalmology; ] * pharmaceutical preparations for ophthalmological use; * pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 1, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 10, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 10, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 13, 2024CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 21, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 21, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
May 13, 2020INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Feb 17, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 23, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jun 4, 2019CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jun 4, 2019COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jun 4, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 3, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 3, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 4, 2018GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Sep 4, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 10, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 19, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 30, 2018NPUBNOTICE OF PUBLICATION—
May 15, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 11, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 10, 2018DOCKASSIGNED TO EXAMINER—
May 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 3, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance